{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:13:09Z","timestamp":1783969989758,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s42770-023-01132-w","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:01:51Z","timestamp":1697169711000},"page":"2799-2805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quinoline-2-one derivatives as promising antibacterial agents against multidrug-resistant Gram-positive bacterial strains"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7771-3885","authenticated-orcid":false,"given":"Hayat Ali","family":"Alzahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"1132_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7173-7","volume":"19","author":"M Lomazzi","year":"2019","unstructured":"Lomazzi M, Moore M, Johnson A, Balasegaram M, Borisch B (2019) Antimicrobial resistance\u2013moving forward? BMC pub health 19:1\u20136","journal-title":"BMC pub health"},{"issue":"1","key":"1132_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/jgid.jgid_110_18","volume":"11","author":"A Chokshi","year":"2019","unstructured":"Chokshi A, Sifri Z, Cennimo D, Horng H (2019) Global contributors to antibiotic resistance. J Global Infect Dis 11(1):36\u201342","journal-title":"J Global Infect Dis"},{"issue":"11","key":"1132_CR3","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","volume":"13","author":"ME de Kraker","year":"2016","unstructured":"de Kraker ME, Stewardson AJ, Harbarth S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 13(11):e1002184","journal-title":"PLoS Med"},{"issue":"10325","key":"1132_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655","journal-title":"Lancet"},{"issue":"1","key":"1132_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1749-6632.2010.05828.x","volume":"1213","author":"MN Gwynn","year":"2010","unstructured":"Gwynn MN, Portnoy A, Rittenhouse SF, Payne DJ (2010) Challenges of antibacterial discovery revisited. Ann N Y Acad Sci 1213(1):5\u201319","journal-title":"Ann N Y Acad Sci"},{"key":"1132_CR6","doi-asserted-by":"crossref","unstructured":"Abushaheen MA, Fatani AJ, Alosaimi M, Mansy W, George M, Acharya S et al (2020) Antimicrobial resistance, mechanisms and its clinical significance Disease-a-Month. 66(6):100971","DOI":"10.1016\/j.disamonth.2020.100971"},{"issue":"12","key":"1132_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1080\/17512433.2016.1241141","volume":"9","author":"J Rello","year":"2016","unstructured":"Rello J, Bunsow E, Perez A (2016) What if there were no new antibiotics? A look at alternatives. Expert Rev Clin Pharmacol 9(12):1547\u20131555","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"1132_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/138920210793360925","volume":"11","author":"S Askari","year":"2010","unstructured":"Askari S, B, Krajinovic M. (2010) Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes. Curr Genomics 11(8):578\u2013583","journal-title":"Curr Genomics"},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2323-y","volume":"17","author":"S Eshetie","year":"2017","unstructured":"Eshetie S, Gizachew M, Dagnew M, Kumera G, Woldie H, Ambaw F et al (2017) Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis 17:1\u201312","journal-title":"BMC Infect Dis"},{"issue":"Pt 9","key":"1132_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1099\/jmm.0.043513-0","volume":"61","author":"RR Watkins","year":"2012","unstructured":"Watkins RR, David MZ, Salata RA (2012) Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J Med Microbiol 61(Pt 9):1179","journal-title":"J Med Microbiol"},{"key":"1132_CR11","volume-title":"Investigation of post-translational modifications in Staphylococcus aureus","author":"CN Krute","year":"2015","unstructured":"Krute CN (2015) Investigation of post-translational modifications in Staphylococcus aureus. University of South Florida"},{"issue":"12","key":"1132_CR12","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3201\/eid1312.070629","volume":"13","author":"E Klein","year":"2007","unstructured":"Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005. Emerg Infect Dis 13(12):1840","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1132_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/10807039.2012.688702","volume":"18","author":"SJ Harris","year":"2012","unstructured":"Harris SJ, Cormican M, Cummins E (2012) Antimicrobial residues and antimicrobial-resistant bacteria: impact on the microbial environment and risk to human health\u2014a review. Hum Ecol Risk Assess Int J 18(4):767\u2013809","journal-title":"Hum Ecol Risk Assess Int J"},{"issue":"7","key":"1132_CR14","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/JB.187.7.2426-2438.2005","volume":"187","author":"SR Gill","year":"2005","unstructured":"Gill SR, Fouts DE, Archer GL, Mongodin EF, DeBoy RT, Ravel J et al (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187(7):2426\u20132438","journal-title":"J Bacteriol"},{"issue":"4","key":"1132_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/CMR.13.4.686","volume":"13","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya Y, Falk P, Mayhall CG (2000) Vancomycin-resistant enterococci. Clin Microbiol Rev 13(4):686\u2013707","journal-title":"Clin Microbiol Rev"},{"issue":"22","key":"1132_CR16","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","volume":"173","author":"E Zimlichman","year":"2013","unstructured":"Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK et al (2013) Health care\u2013associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 173(22):2039\u20132046","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1132_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40843-021-1735-0","volume":"65","author":"T Feng","year":"2022","unstructured":"Feng T, Lu H, Ye X, Nie C, Zhang J, Yu L et al (2022) Selective inactivation of Gram-positive bacteria in vitro and in vivo through metabolic labelling. Sci China Mater 65(1):237\u2013245","journal-title":"Sci China Mater"},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00277-020-04144-w","volume":"99","author":"R Kara Ali","year":"2020","unstructured":"Kara Ali R, Surme S, Balkan II, Salihoglu A, Sahin Ozdemir M, Ozdemir Y et al (2020) An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality. Ann Hematol 99:1925\u20131932","journal-title":"Ann Hematol"},{"issue":"17","key":"1132_CR19","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1021\/acs.jmedchem.6b00640","volume":"59","author":"P Teng","year":"2016","unstructured":"Teng P, Huo D, Nimmagadda A, Wu J, She F, Su M et al (2016) Small antimicrobial agents based on acylated reduced amide scaffold. J Med Chem 59(17):7877\u20137887","journal-title":"J Med Chem"},{"issue":"5","key":"1132_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.28","volume":"2","author":"JM Stokes","year":"2017","unstructured":"Stokes JM, MacNair CR, Ilyas B, French S, C\u00f4t\u00e9 J-P, Bouwman C et al (2017) Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nat Microbiol 2(5):1\u20138","journal-title":"Nat Microbiol"},{"issue":"41","key":"1132_CR21","doi-asserted-by":"publisher","first-page":"10706","DOI":"10.1002\/anie.201209979","volume":"52","author":"KM O'Connell","year":"2013","unstructured":"O'Connell KM, Hodgkinson JT, Sore HF, Welch M, Salmond GP, Spring DR (2013) Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials. Angewandte Chemie Int Ed 52(41):10706\u201310733","journal-title":"Angewandte Chemie Int Ed"},{"issue":"7535","key":"1132_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP et al (2015) A new antibiotic kills pathogens without detectable resistance. Nature 517(7535):455\u2013459","journal-title":"Nature"},{"issue":"4","key":"1132_CR23","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1021\/acs.jmedchem.6b01403","volume":"60","author":"S Lin","year":"2017","unstructured":"Lin S, Koh J-J, Aung TT, Lim F, Li J, Zou H et al (2017) Symmetrically substituted xanthone amphiphiles combat gram-positive bacterial resistance with enhanced membrane selectivity. J Med Chem 60(4):1362\u20131378","journal-title":"J Med Chem"},{"issue":"14","key":"1132_CR24","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1021\/acs.jmedchem.6b00726","volume":"59","author":"MJ LaMarche","year":"2016","unstructured":"LaMarche MJ, Leeds JA, Brewer J, Dean K, Ding J, Dzink-Fox J et al (2016) Antibacterial and solubility optimization of thiomuracin A. J Med Chem 59(14):6920\u20136928","journal-title":"J Med Chem"},{"key":"1132_CR25","doi-asserted-by":"crossref","unstructured":"Aly AA, Ramadan M, Abuo-Rahma GE-DA, Elshaier YAMM, Elbastawesy MAI, Brown AB, et al. Chapter three-quinolones as prospective drugs: their syntheses and biological applications. Adv Heterocy Chem. 135: Academic Press; (2021).147-196.","DOI":"10.1016\/bs.aihch.2020.08.001"},{"issue":"3","key":"1132_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2174\/1570179417666201216162055","volume":"18","author":"M Dib","year":"2021","unstructured":"Dib M, Ouchetto H, Ouchetto K, Hafid A, Khouili M (2021) Recent Developments of quinoline derivatives and their potential biological activities. Curr Org Synth 18(3):248\u2013269","journal-title":"Curr Org Synth"},{"key":"1132_CR27","doi-asserted-by":"crossref","unstructured":"Srivastava V, Singh PK, Tivari S, Singh PP. Visible light photocatalysis in the synthesis of pharmaceutically relevant heterocyclic scaffolds. Organic Chemistry Front 2022;9(5):1485-1507.","DOI":"10.1039\/D1QO01602D"},{"issue":"29","key":"1132_CR28","doi-asserted-by":"publisher","first-page":"18594","DOI":"10.1039\/D2RA02896D","volume":"12","author":"OO Ajani","year":"2022","unstructured":"Ajani OO, Iyaye KT, Ademosun OT (2022) Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs - a review. RSC Adv 12(29):18594\u201318614","journal-title":"RSC Adv"},{"key":"1132_CR29","doi-asserted-by":"publisher","first-page":"115973","DOI":"10.1016\/j.bmc.2020.115973","volume":"32","author":"BS Matada","year":"2021","unstructured":"Matada BS, Pattanashettar R, Yernale NG (2021) A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg Med Chem 32:115973","journal-title":"Bioorg Med Chem"},{"key":"1132_CR30","first-page":"12","volume":"12","author":"E Al-Jumaily","year":"2016","unstructured":"Al-Jumaily E, Latif A, Al-Bayati R (2016) Effect of a new quinoline-2-one derivatives (compound 3) on purified DNA gyrase from clinical isolate Pseudomonas aeruginosa PA31. IOSR J Pharmacy 12:12\u201318","journal-title":"IOSR J Pharmacy"},{"issue":"19","key":"1132_CR31","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2174\/1385272821666170711155631","volume":"21","author":"K Proisl","year":"2017","unstructured":"Proisl K, Kafka S, Kosmrlj J (2017) Chemistry and applications of 4-hydroxyquinolin-2-one and quinoline-2, 4-dionebased compounds. Curr Org Chem 21(19):1949\u20131975","journal-title":"Curr Org Chem"},{"issue":"5","key":"1132_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/antibiotics11050641","volume":"11","author":"O Estrad\u00e9","year":"2022","unstructured":"Estrad\u00e9 O, Vozmediano V, Carral N, Isla A, Gonz\u00e1lez M, Poole R et al (2022) Key factors in effective patient-tailored dosing of fluoroquinolones in urological infections: interindividual pharmacokinetic and pharmacodynamic variability. Antibiotics 11(5):641\u2013652","journal-title":"Antibiotics"},{"issue":"23","key":"1132_CR33","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.3390\/molecules26237153","volume":"26","author":"AR Millanao","year":"2021","unstructured":"Millanao AR, Mora AY, Villagra NA, Bucarey SA, Hidalgo AA (2021) Biological effects of quinolones: a family of broad-spectrum antimicrobial agents. Molecules 26(23):7153\u20137163","journal-title":"Molecules"},{"key":"1132_CR34","doi-asserted-by":"crossref","unstructured":"Fair RJ, Tor Y (2014) Antibiotics and bacterial resistance in the 21st century. Perspect med chem 6; PMC. S14459","DOI":"10.4137\/PMC.S14459"},{"issue":"1","key":"1132_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","volume":"1354","author":"DC Hooper","year":"2015","unstructured":"Hooper DC, Jacoby GA (2015) Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci 1354(1):12\u201331","journal-title":"Ann N Y Acad Sci"},{"key":"1132_CR36","doi-asserted-by":"crossref","unstructured":"Elbastawesy MA, Mohamed FA, Zaki I, Alahmdi MI, Alzahrani SS, Alzahrani HA et al (2023) Design, synthesis and antimicrobial activity of novel quinoline-2-one hybrids as promising DNA gyrase and topoisomerase IV inhibitors. J Mol Struct 1278:134902","DOI":"10.1016\/j.molstruc.2023.134902"},{"issue":"2","key":"1132_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21608\/bfsa.2013.63201","volume":"36","author":"BGM Youssif","year":"2013","unstructured":"Youssif BGM (2013) Synthesis and biological evaluation of some new coumarin derivatives as antimicrobial agents. Bullet Pharmaceut Sci Assiut 36(2):105\u2013116","journal-title":"Bullet Pharmaceut Sci Assiut"},{"key":"1132_CR38","first-page":"54","volume":"4","author":"B Youssif","year":"2014","unstructured":"Youssif B, Abdel-Moty SG, Sayed IM (2014) Synthesis and biological evaluation of some novel 1, 2, 3-triazol-N-arylidene Acetohydrazide incorporating benzimidazole ring moiety as potential antimicrobial agents. J Curr Chem Pharm Sci 4:54\u201364","journal-title":"J Curr Chem Pharm Sci"},{"key":"1132_CR39","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.bioorg.2021.104920","volume":"112","author":"HA Hofny","year":"2021","unstructured":"Hofny HA, Mohamed MF, Gomaa HA, Abdel-Aziz SA, Youssif BG, El-Koussi NA et al (2021) Design, synthesis, and antibacterial evaluation of new quinoline-1, 3, 4-oxadiazole and quinoline-1, 2, 4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Bioorg Chem 112:104920","journal-title":"Bioorg Chem"},{"issue":"1","key":"1132_CR40","doi-asserted-by":"publisher","first-page":"103538","DOI":"10.1016\/j.arabjc.2021.103538","volume":"15","author":"FOA Frejat","year":"2022","unstructured":"Frejat FOA, Cao Y, Zhai H, Abdel-Aziz SA, Gomaa HA, Youssif BG et al (2022) Novel 1, 2, 4-oxadiazole\/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity. Arab J Chem 15(1):103538","journal-title":"Arab J Chem"},{"key":"1132_CR41","doi-asserted-by":"publisher","first-page":"105922","DOI":"10.1016\/j.bioorg.2022.105922","volume":"126","author":"FOA Frejat","year":"2022","unstructured":"Frejat FOA, Zhai H, Cao Y, Wang L, Mostafa YA, Gomaa HA et al (2022) Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: synthesis and biological evaluation. Bioorg Chem 126:105922","journal-title":"Bioorg Chem"},{"issue":"5","key":"1132_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ph14050399","volume":"14","author":"LH Al-Wahaibi","year":"2021","unstructured":"Al-Wahaibi LH, Amer AA, Marzouk AA, Gomaa HA, Youssif BG, Abdelhamid AA (2021) Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors. Pharmaceut 14(5):399","journal-title":"Pharmaceut"},{"issue":"5","key":"1132_CR43","doi-asserted-by":"publisher","first-page":"104107","DOI":"10.1016\/j.jece.2020.104107","volume":"8","author":"RM Abdelhameed","year":"2020","unstructured":"Abdelhameed RM, Abu-Elghait M, El-Shahat M (2020) Hybrid three MOFs composites (ZIF-67@ ZIF-8@ MIL-125-NH2): enhancement the biological and visible-light photocatalytic activity. J Environ Chem Eng 8(5):104107","journal-title":"J Environ Chem Eng"},{"key":"1132_CR44","unstructured":"Rashid N, Thapliyal C, Chattopadhyay PC (2016) Dihydrofolate reductase as a versatile drug target in healthcare. J Proteins Proteom 7(4)"},{"key":"1132_CR45","doi-asserted-by":"publisher","first-page":"105616","DOI":"10.1016\/j.bioorg.2022.105616","volume":"120","author":"HA Gomaa","year":"2022","unstructured":"Gomaa HA, Shaker ME, Alzarea SI, Hendawy O, Mohamed FA, Gouda AM et al (2022) Optimization and SAR investigation of novel 2, 3-dihydropyrazino [1, 2-a] indole-1, 4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities. Bioorg Chem 120:105616","journal-title":"Bioorg Chem"},{"key":"1132_CR46","doi-asserted-by":"publisher","first-page":"104369","DOI":"10.1016\/j.bioorg.2020.104369","volume":"105","author":"HA Gomaa","year":"2020","unstructured":"Gomaa HA, El-Sherief HA, Hussein S, Gouda AM, Salem OI, Alharbi KS et al (2020) Novel 1, 2, 4-triazole derivatives as apoptotic inducers targeting p53: synthesis and antiproliferative activity. Bioorg Chem 105:104369","journal-title":"Bioorg Chem"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-01132-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T03:18:26Z","timestamp":1701400706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-01132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-01132-w","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}